Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
Research from World Health Organization broadens understanding of HIV/AIDS
April 29th, 2009
"HIV vaccines of the first generation are, in contrast to most currently licensed vaccines, unlikely to provide sterilizing immunity against infection with HIV. However, they are expected to exert a beneficial effect on the maintenance of CD4 T-cell counts by reducing viral load," scientists in Geneva, Switzerland report. "There is a recognized need for clarifying the path to licensure of such novel vaccines and defining the clinical trial endpoints. This was the focus of discussions of a 2-day workshop organized by the WHO, UNAIDS and the ANRS, in support of the Global HIV Vaccine Enterprise, which took place in Paris, France (5-6 September 2007). This expert...
Source: Vaccine Weekly (2009-04-29)
|
